Invenomic Capital Management’s Immersion IMMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,534,323
Closed -$10.8M 159
2022
Q4
$10.8M Sell
1,534,323
-134,838
-8% -$868K 0.73% 46
2022
Q3
$9.16M Hold
1,669,161
0.79% 45
2022
Q2
$8.91M Hold
1,669,161
0.63% 52
2022
Q1
$7.65M Sell
1,669,161
-29,394
-2% -$152K 0.82% 37
2021
Q4
$9.7M Buy
1,698,555
+754,286
+80% +$4.96M 2.07% 9
2021
Q3
$6.46M Buy
944,269
+665,705
+239% +$4.97M 2.1% 10
2021
Q2
$2.44M Buy
+278,564
New +$2.39M 0.59% 40
2020
Q4
Sell
-124,038
Closed -$874K 157
2020
Q3
$874K Sell
124,038
-12,472
-9% -$94K 0.48% 69
2020
Q2
$850K Buy
136,510
+56,909
+71% +$367K 0.63% 57
2020
Q1
$426K Buy
+79,601
New +$550K 0.35% 82

Other funds holding IMMR

Invenomic Capital Management's IMMR Position: Q1 2023 in Review

Invenomic Capital Management sold out of Immersion (IMMR) in Q1 2023, closing a stake of 1,534,323 shares — an estimated $10.8M sold.

Invenomic Capital Management first reported a position in IMMR in Q1 2020 and held it in 10 quarters. The position peaked at $10.8M in Q4 2022. 123 funds tracked by Wall St. Rank hold IMMR as of Q1 2023.

  • Invenomic Capital Management reported no remaining Immersion position as of Q1 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 1,534,323 Immersion shares in Q1 2023, an estimated $10.8M.
  • Invenomic Capital Management first reported a position in Immersion in Q1 2020 and held it in 10 quarters.
  • Invenomic Capital Management's Immersion position peaked at $10.8M in Q4 2022.
  • 123 funds tracked by Wall St. Rank held Immersion as of Q1 2023.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.